Schedule change for bisacodyl 5 mg tablets and 10 mg suppositories

Effective January 21, 2014:

• Bisacodyl - when sold in concentrations of 5 mg or less per oral dosage unit or 10 mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50 mg of bisacodyl -  Unscheduled status (from Schedule III)
   
• Bisacodyl and its salts [except when sold in concentrations of 5 mg or less per oral dosage unit or 10 mg or less per rectal dosage unit/suppository in package sizes containing no more than 50 mg of bisacodyl]  - remains in Schedule III